Explore every episode of the podcast CEimpact Podcast
Dive into the complete episode list for CEimpact Podcast. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.
Rows per page:
50
1–50 of 389
Title
Pub. Date
Duration
New Drugs You Need to Know About
30 Sep 2024
00:33:59
In today’s landscape of direct-to-consumer advertising, pharmacists are a vital source of guidance for both healthcare providers and patients seeking information on newly FDA-approved medications. Staying up-to-date on the latest drug approvals is crucial for pharmacists to ensure accurate dispensing and to offer thorough education to patients and other providers. This episode highlights several medications approved by the FDA in the last 12 to 18 months, providing essential insights into their clinical use.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
GUEST Joe Strain, PharmD Professor Pharmacy Practice South Dakota State University
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. List unique pharmacological properties for each medication recently approved by the FDA. 2. Recall common side effects, contraindications, known drug interactions, and/or warnings associated with each new medication.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-267-H01-P Initial release date: 9/30/2024 Expiration date: 9/30/2025 Additional CPE details can be found here.
In an era where informed decisions are crucial to public health, understanding vaccine hesitancy has never been more critical.
Listen in to this week’s GC episode to learn actionable steps you can make today to break down vaccine hesitancy barriers and provide an accurate and data-driven approach to vaccine education in your community.
HOST Jen Moulton, BSPharm President CEimpact
GUEST Lacy Epperson, PharmD Director of Pharmacy Clinical Services Mitchell's Drug Stores
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Analyze the underlying factors contributing to vaccine hesitancy and their effects on public health. 2. Discuss effective communication and outreach strategies to increase vaccination rates within a pharmacys community.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-262-H06-P Initial release date: 9/23/2024 Expiration date: 9/23/2025 Additional CPE details can be found here.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea. 2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-238-H01-P Initial release date: 07/29/2024 Expiration date: 07/29/2025 Additional CPE details can be found here.
Long COVID, or PostAcute Sequelae of SARS-CoV-2 Infection (PASC), was identified early in the pandemic. With over 200 symptoms attributed to PASC, join host, Geoff Wall, as he evaluates a seminal paper describing the diagnostic criteria, symptoms, and incidence of Long COVID.
The GameChanger The PASC score can be used to detect Long COVID and help establish patients into care.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Thaweethai T, Jolley SE, Karlson EW, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. Published online May 25, 2023. doi:10.1001/jama.2023.8823
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Apply the PASC score to a patient with Long COVID. 2. Describe the limitations of the RECOVER study.
0.05 CEU/0.5 Hr UAN: 0107-0000-23-236-H01-P Initial release date: 7/3/2023 Expiration date: 7/3/2024 Additional CPE details can be found here.
This podcast episode was financially supported through grant funding from Ananda Professional.
Non-alcoholic fatty liver disease (NAFLD) is a primary cause of chronic liver disease and cirrhosis. Join host, Geoff Wall, as he evaluates new data on the diagnosis and treatment of NAFLD.
The GameChanger Historical treatment of NAFLD includes beta-blockers, diuretics, and lactulose for hepatic encephalopathy. Newer agents include statins, pioglitazone, and even vitamin E.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the treatment of cirrhosis and subsequent complications 2. Develop treatment recommendations for persons with NAFLD
0.05 CEU/0.5 Hr UAN: 0107-0000-23-235-H01-P Initial release date: 6/26/2023 Expiration date: 6/26/2024 Additional CPE details can be found here.
This podcast episode was financially supported through grant funding from Ananda Professional.
Many of us avoid giving feedback because it can feel negative and uncomfortable. We’re afraid of a poor reaction from the student and we really don’t want to hurt their feelings – after all – they already have so much pressure on them. And let’s be honest - sometimes, we just want to be liked.
And yet as preceptors, giving good feedback is probably one of the most important jobs we have. If our learners – whether students or residents - are going to be successful, deliver excellent patient care, and even keep patients safe, they’ve got to hear some tough feedback every now and again. If we’re being truthful – so do we.
Dr. Shannon James from Husson University joined me for a discussion about giving good feedback to learners. Her thoughtful and fearless approach to this really resonated with me and I hope it does for you, too.
Host Kathy Schott, PhD CEimpact
Guest Shannon James, PharmD, BCPP Assistant Professor of Pharmacy Practice Husson University School of Pharmacy
About Dr. James: Dr. Shannon James is a Board Certified Psychiatric Pharmacist and an Assistant Professor of Pharmacy Practice at the Husson University School of Pharmacy. Shannon earned B.S. Pharmaceutical Studies and Doctor of Pharmacy degrees at the University of Kansas. After graduation, she completed a PGY1 Pharmacy Practice residency at the New Mexico VA Health Care System in Albuquerque, NM followed by a PGY2 Psychiatric Pharmacy residency at Community Health Network and Butler University in Indianapolis, IN. She is a certified Mental Health First Aid instructor and is involved in grant-funded efforts to improve access to harm reduction resources for opioid use disorder in Maine. Her clinical interests include severe mental illness, substance use disorders, and patient advocacy.
CE Information At the end of this course, preceptors will be able to: 1. Describe strategies for effective feedback. 2. Discuss how establishing a set of core assumptions about learners can assist in delivering effective feedback.
The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Want more information on this and related topics?
Providing Effective Feedback Many of us avoid giving feedback because it can feel negative, however, it is essential for growth and quality communication. The evidence-based methods discussed in this course give you skills to provide effective feedback that facilitates learning and empowers students and residents.
Using Feedback to Improve Your Teaching Feedback is essential to developing a trusting and safe environment where learners can grow in their confidence. This course will give you some proven strategies for accepting and implementing critical feedback on your teaching.
Guidelines for Heart Failure with Preserved Ejection Fraction
19 Jun 2023
00:24:17
Half of patients with heart failure have Heart Failure with Preserved Ejection Fraction (HFpEF). Join host, Geoff Wall, as he talks about the new guidelines from the American College of Cardiology for diagnosis, treatment, and challenges in therapy for persons with HFpEF.
The GameChanger HFpEF is the fastest growing cause of heart failure and is often difficult to diagnose. New therapies are shown to improve symptoms and decrease hospitalizations. Management of comorbid conditions, like obesity and diabetes, is critical to optimizing care.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Kittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. Epub 2023 Apr 19. PMID: 37137593.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the H2FPEF scoring system for HFpEF diagnosis 2. Apply the new practice guidelines to HFpEF patient pharmacotherapy
0.05 CEU/0.5 Hr UAN: 0107-0000-23-228-H01-P Initial release date: 6/19/2023 Expiration date: 6/19/2024 Additional CPE details can be found here.
Adulteration of medications of abuse is a rampant issue in the US. Most attention is on opioids; however, benzodiazepine adulteration is occurring – with sulfonylureas. Join host, Geoff Wall, as he talks about managing emergent hypoglycemia episodes.
The GameChanger Several case reports have detailed patients unresponsive due to severe hypoglycemia caused by mistaken sulfonylurea ingestion. Treatment of acute sulfonylurea overdose includes dextrose and octreotide.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
References and Resources Tucker, M. Sulfonylureas as Street Drugs: Hidden Hypoglycemia Cause. Medscape. May 2023. https://www.medscape.com/viewarticle/991680
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the phenomenon of ‘street valium’ overdoses 2. Discuss the treatment of severe sulfonylurea overdose
0.05 CEU/0.5 Hr UAN: 0107-0000-23-227-H01-P Initial release date: 6/12/2023 Expiration date: 6/12/2024 Additional CPE details can be found here.
Septic shock has a 40% mortality rate in many patients. Methylene blue has been shown in small non-controlled case series to have a benefit. Join host, Geoff Wall, as he reviews a randomized controlled study from Mexico on this novel strategy.
The GameChanger Methylene blue is a specific inhibitor of the inducible nitric oxide synthase for indirect pressor effects. Despite confounders, this small study may be a good start for a larger randomized controlled study for methylene blue as early adjunct care in patients with septic shock.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Ibarra-Estrada M, Kattan E, Aguilera-González P, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023 Mar 13;27(1):110. doi: 10.1186/s13054-023-04397-7. PMID: 36915146; PMCID: PMC10010212.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the potential physiologic mechanism of benefit for methylene blue in septic shock 2. Discuss the Ibarra-Estrada et al study limitations
0.05 CEU/0.5 Hr UAN: 0107-0000-23-212-H01-P Initial release date: 6/5/2023 Expiration date: 6/5/2024 Additional CPE details can be found here.
The proverbial ‘pill’ or hormonal contraception may be available over-the-counter (or at least a progestin-only version) by year’s end. Join guest host, Jake Galdo, as he discusses improved access to care with Erin Raney as the FDA debates over-the-counter status for hormonal contraceptives.
The GameChanger Women’s health is a priority area from a public health perspective – the US has lots of room for improvement. One initiative is to allow a progestin-only hormonal contraceptive have over-the-counter status; in other words, be available without a prescription. Progestin-only therapy has unique counseling considerations, so pharmacy intervention can help to optimize care.
Host Jake Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Managing Network Facilitator, CPESN Health Equity CEO, Seguridad
Guest Erin C. Raney, Pharm.D., BCPS, BC-ADM Professor of Pharmacy Practice Midwestern University College of Pharmacy-Glendale
References and Resources Opill Rx-to-OTC Switch Program. www.fda.gov/media/167893/download
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the efficacy of OTC hormonal contraceptive 2. Identify contraindications for OTC hormonal contraceptives
Sexually transmitted infection (STI) risk in high risk patients is a common problem compounded by antimicrobial resistance. Join host, Geoff Wall, with guest Amanda Bushman, as they discuss a new post-exposure prophylaxis (PEP) therapy for STI prevention
The GameChanger Sexually transmitted infection incidence is higher than most clinicians suspect. Doxycycline may offer effective post-exposure prophylaxis for some HIV positive patients.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Guest Amanda Bushman, PharmD, BCIDP Clinical Pharmacist UnityPoint Health
References Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023 Apr 6;388(14):1296-1306. doi: 10.1056/NEJMoa2211934. PMID: 37018493; PMCID: PMC10140182.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the DOXY-PEP study 2. Apply results of DOXY-PEP to patient care
0.05 CEU/0.5 Hr UAN: 0107-0000-23-205-H01-P Initial release date: 5/22/2023 Expiration date: 5/22/2024 Additional CPE details can be found here.
1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death.
The GameChanger The study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer.
Guest Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the use of multivitamins. 2. Identify implications for healthy patients considering multivitamin use.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-226-H01-P Initial release date: 07/22/2024 Expiration date: 07/22/2025 Additional CPE details can be found here.
While we all know students who may exhibit more confidence that they have the right to based on their actual knowledge and experience, more often as preceptors we have students who demonstrate a lack of confidence that gets in the way of their learning. It is easy to make assumptions about why a student demonstrates a lack of confidence, but often we have missed the mark. By understanding the root cause of waning confidence in a pharmacy learner, we can develop strategies to increase confidence and allow them to optimize their learning.
Dr. Kate Newman, Director of Experiential Education, and Dr. Stephanie Hunziker, Director of Skills and Simulation and a Clinical Assistant Professor are both from Southern Illinois University Edwardsville School of Pharmacy. They have recognized the negative impact that low confidence can have on learner outcomes and have lots to share about challenges and strategies for identifying the root cause of low confidence, as well as teaching tactics and methods to overcome them.
Host Kathy Schott, PhD CEimpact
Guests Kate Newman, PharmD Director of Experiential Education Clinical Associate Professor, Pharmacy Practice Southern Illinois University Edwardsville, School of Pharmacy
Stephanie Hunziker, PharmD Director of Skills and Simulation Clinical Assistant Professor Southern Illinois University Edwardsville School of Pharmacy
At the end of this course, preceptors will be able to:
1. Recognize potential reasons as learner may appear to lack confidence in a clinical setting. 2. Discuss strategies to help students overcome barriers and increase confidence.
UAN: 0107-0000-23-208-H99-P Release Date: 05/17/2023 Expiration Date: 05/17/2026 The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Pharmacy learners are innately afraid to look silly, say the wrong thing, or make mistakes that could result in negative feedback. This fear can manifest in a perceived lack of confidence. This course provides pearls for creating an safe and supportive environment where failure isn’t something to be ashamed of, but rather a path to greater learning.
We’ve also got a great podcast on this topic. Check out Season 2, Episode 1.
Feedback is essential to developing a trusting and safe environment where learners can grow in their confidence. This course will give you some proven strategies for accepting and implementing critical
About 50% of Americans have hypertension, yet WHICH is a preferred anti-hypertensive strategy is a random process. And pharmacogenomics may not be needed. Join host, Geoff Wall, as he evaluates a recent study evaluating the role of personalized medication selection for persons with hypertension.
The GameChanger Although no genetic markers exist to determine optimal hypertensive pharmacotherapy, initial and secondary hypertensive therapy does impact outcomes. A personalized approach does produce a greater reduction in blood pressure.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Sundström J, Lind L, Nowrouzi S, et al. Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial. JAMA. 2023;329(14):1160–1169. doi:10.1001/jama.2023.3322
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the results of the PHYSIC study 2. Discuss the limitations of the PHYSIC study
0.05 CEU/0.5 Hr UAN: 0107-0000-23-205-H01-P Initial release date: 5/22/2023 Expiration date: 5/22/2024 Additional CPE details can be found here.
Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 2 of a two-part series examining new research on the proposed RSV vaccine.
The GameChanger RSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in pregnant patients may help newborns.
Show Segments 00:00 - Introductions 02:57 - Recap From Part 1 06:45 - Looking at the MATISSE Study 14:17 - The GameChanger: MATISSE Results 22:27 - Connecting to Practice: Barriers to Applying 31:05 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the MATISSE study in relation to RSV vaccines 2. Describe barriers to applying the information in this study to general populations
0.05 CEU/0.5 Hr UAN: 0107-0000-23-193-H06-P Initial release date: 05/08/2023 Expiration date: 05/08/2024 Additional CPE details can be found here.
Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 1 of a two-part series examining new research on the proposed RSV vaccine.
The GameChanger RSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in older adults improves antibody titers.
Show Segments 00:00 - Introductions 03:06 - Barriers to Development of the RSV Vaccine 06:46 - Looking at the RSV Vaccine Study 13:01 - The GameChanger: The Vaccine Outcomes 20:57 - Connecting to Practice: The Potential Future of This Vaccine 28:19 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
CE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe barriers to development of an RSV vaccine 2. Discuss outcomes of an RSV vaccines in older adults
Community Acquired Pneumonia (CAP) has a high mortality rate. A new study evaluates the use of hydrocortisone for severe CAP in the ICU setting. Join host, Geoff Wall, as he evaluates if the evidence stacks up.
The GameChanger The use of steroids to treat severe pneumonia has waxed and waned for many years with insufficient evidence. A recent study found steroids improved a number of outcomes, including mortality.
Show Segments 00:00 - Introductions 01:19 - Past Studies on CAP Treatment 03:32 - The CAPE Code Study 17:05 - The GameChanger: The Study Findings 24:31 - Connecting to Practice: Study Limitations 26:01 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the past history of major mortality studies for CAP pharmacotherapy 2. Discuss the CAPE Code study and its possible implications in the ICU
0.05 CEU/0.5 Hr UAN: 0107-0000-23-147-H01-P Initial release date: 04/24/2023 Expiration date: 04/24/2024 Additional CPE details can be found here.
Co-precepting can help with workload while providing a diverse experience for learners, but it is not without its challenges. Listen in to weigh the pros and cons while gathering some strategies to ensure success if you plan to consider, or are currently, co-precepting with a colleague.
Kate Newman is the Director of Experiential Education at Southern Illinois University Edwardsville School of Pharmacy. She’s been seeing more co-precepting arrangements with her affiliate experiential education sites and has seen what works, and of course what doesn’t work. I asked her to share some tips and strategies with me that have helped ensure a good learning experience at sites where preceptors are sharing the teaching load. Listen in!
Host Kathy Schott, PhD CEimpact
Guests Kate Newman, PharmD Director of Experiential Education Clinical Associate Professor, Pharmacy Practice Southern Illinois University Edwardsville, School of Pharmacy
At the end of this course, preceptors will be able to:
1. Describe co-precepting and the pros and cons commonly associated with it.
2. Identify potential challenges and strategies to address them.
UAN: 0107-0000-23-149-H99-P Release Date: 04/19/2023 Expiration Date: 04/19/2026 The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Feedback may be more important than ever when working in a co-precepting environment – from students and from your fellow co-preceptors. This course will give you some proven strategies for accepting and implementing critical feedback on your teaching.
Preceptors often don’t feel they have time or know how to go about creating an appropriate amount of structure within the experiences they provide for student pharmacists. In this CPE course, preceptors have the opportunity to learn and apply simple quality improvement techniques to maintain and enhance their learning experience.
Regardless of your precepting environment, there’s always room for self-assessment. This tool will allow you to assess your own strengths and areas for development as a preceptor so that you can develop your own professional development plan as a teacher and mentor.
As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask you experiential program director if you are a member so that you can access it all for free!
Several studies have found the improved outcomes and quality of life through deprescribing. However, it rarely happens. Join host, Geoff Wall, with guest, Kristin Meyer, as they evaluate a new studying looking at pharmacist-provided describing services during transition of care.
The GameChanger Older patients are on numerous medications often with limited therapeutic benefit and high risk of adverse events. Many of these medications can be discontinued with no change in outcomes. Pharmacists are uniquely positioned to support deprescribing protocols.
Show Segments 00:00 - Introductions 01:46 - Arguments for Deprescribing 05:44 - Looking at the Study 16:32 - The GameChanger: Deprescribing Results 22:42 - Connecting to Practice: Dr. Meyer’s Thoughts on Results 31:08 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Guest Kristin Meyer, PharmD, BCGP Professor of Pharmacy Practice, Drake University
References and Resources
Vasilevskis EE, Shah AS, Hollingsworth EK, et al. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial. JAMA Intern Med. 2023;183(3):223–231. doi:10.1001/jamainternmed.2022.6545
O'Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. doi: 10.1080/17512433.2020.1697676. Epub 2019 Nov 30. PMID: 31790317.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the importance and benefits of deprescribing medications in elderly patients 2. Discuss the assessment scoring systems used to assess deprescribing activities
0.05 CEU/0.5 Hr UAN: 0107-0000-23-146-H01-P Initial release date: 04/17/2023 Expiration date: 04/17/2024 Additional CPE details can be found here.
ICU patients are at high risk for venous thromboembolism, and the majority of patients require prophylaxis. The challenging therapy is thrombocytopenia. Join host Geoff Wall, as he evaluates the results of a new study evaluating the clinical thresholds for chemical prophylaxis.
The GameChanger The majority of ICU patients eligible for VTE prophylaxis do not receive it. Different clinicians use different thresholds to initiate or stop prophylaxis. The database study discussed provides a potential evidence-based threshold.
Show Segments 00:00 - Introductions 00:47 - VTE Prophylaxis Background 09:34 - Looking at the Study 18:42 - The GameChanger: A Potential Threshold for Chemical Prophylaxis 22:15 - Connecting to Practice: Applicability 26:13 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the history and use of VTE prophylaxis in the ICU 2. Describe the results of the Pang et al study discussed and its applicability to ICU patients
0.05 CEU/0.5 Hr UAN: 0107-0000-23-134-H01-P Initial release date: 04/10/2023 Expiration date: 04/10/2024 Additional CPE details can be found here.
Drug allergies are a common challenge for all prescribers, patients, and pharmacies. They are associated with increased costs, adverse effects, and extended hospitalizations. Join host Geoff Wall as he reviews the newly released AAAI guidelines on drug allergies.
The GameChanger Over 90% of patients claiming a penicillin allergy are not allergic. Sulfamethoxazole desensitization is largely not needed. A thorough evaluation of patient allergies with testing may help establish true allergies in patients and help optimize pharmacotherapy.
Show Segments 00:00 - Introductions 01:55 - Changes in Classifications 07:35 - The GameChanger: Beta-Lactam Allergy Approach 21:05 - Sulfonamide Allergy Approach 27:04 - Non-Steroidal Allergy Approach 30:05 - Connecting to Practice: Applying these Changes 30:58 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss approaches to a patient with a claimed penicillin allergy who requires a beta lactam 2. Discuss the protocol for desensitization for a sulfonamide allergic patient when a sulfonamide is required
0.05 CEU/0.5 Hr UAN: 0107-0000-23-133-H01-P Initial release date: 04/03/2023 Expiration date: 04/03/2024 Additional CPE details can be found here.
Although the numbers may be low, COVID-19 and other illnesses remain a significant threat to patients. The role of masks in preventing SARS-CoV-2 spread has been politicized since the beginning. A new meta-analysis purports to answer the question of mask effectiveness. Join host Geoff Wall, with guest Jake Galdo, as they deep dive into the article and evaluate the science.
The GameChanger A new meta-analysis suggests that mask mandates do not affect the prevention and spread of COVID-19. However, the study has numerous limitations and errors, making its interpretation difficult.
Show Segments 00:00 - Introductions 01:31 - Pros and Cons of a Meta-Analysis 06:31: Looking at the Analysis 10:24 - The GameChanger: Jefferson et al. Results 11:24 - Connecting to Practice: Recognizing Limitations 28:43 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Managing Network Facilitator, CPESN Health Equity CEO, Seguridad
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the pros and cons of a meta-analysis 2. Describe the limitations of the Jefferson et al meta-analysis
0.05 CEU/0.5 Hr UAN: 0107-0000-23-119-H01-P Initial release date: 03/22/2023 Expiration date: 03/22/2024 Additional CPE and CME details can be found here.
Integrating Social Determinants of Health into Experiential Education
17 Jul 2024
00:34:16
While health inequity is considered by many to be the #1 issue in healthcare today, we’re still just learning to talk about it as part of pharmacy education. As preceptors, health equity and social determinants of health may not have been a language we learned as part of our education, and yet we rely on preceptors to help develop our learners in this area. What is our role in incorporating conversations and education around health equity and social determinants of health to better educate our learners in improving the lives of patients?
Guest Sally Arif, PharmD, BCCP Professor of Pharmacy Practice/Clinical Cardiology Pharmacist Midwestern University College of Pharmacy Rush Medical Center Chicago, IL
Learning Objectives At the end of this course, preceptors will be able to: 1. Discuss a preceptor's role in educating student pharmacists and pharmacy residents about social determinants of health 2. Describe strategies preceptors can use to incorporate social determinants of health into their teaching
0.05 CEU/0.5 Hr UAN: 0107-0000-24-210-H99-P Initial release date: 7/17/2024 Expiration date: 7/17/2027 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Pharmacogenomics have long held the promise of using personalized information for drug selection to maximize efficacy and minimize adverse reactions. A new study evaluates the routine use of pharmacogenomic testing to improve safety in a wide range of medications. Join host, Geoff Wall, as he evaluates personalized medicine.
The GameChanger Most studies using routine pharmacogenomic testing in clinical practice have not been significant. However, a new study found a 12 panel pharmacogenomic test did decrease the incidence of patient reported adverse effects compared to usual care. Several limitations still exist preventing widespread implementation.
Show Segments 00:00 - Introductions 01:38 - Genomic Guided Therapy to Date 05:05 - Importance of Genomic Variations 08:37 - Looking at the Study 21:20 - The GameChanger: Swen et al Results 27:50 - Connecting to Practice: Current Barriers to Pharmacogenomic Testing 30:38- Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current barriers to routine use of pharmacogenomic testing 2. Discuss issues and results of the Swen et al study on pharmacogenomics
0.05 CEU/0.5 Hr UAN: 0107-0000-23-118-H01-P Initial release date: 03/20/2023 Expiration date: 03/20/2024 Additional CPE and CME details can be found here.
Pharmacy learners - IPPE, APPE, Residents - may not always be forthcoming with honest feedback. But they know what they appreciate (or don't) in a learning experience. As a preceptor, your approach to teaching has a huge impact on student learning.
We asked two 4th year pharmacy learners to share what matters most to them in a preceptor. Their answers may surprise you! Listen in to learn what students most value in their learning experiences and gather some strategies you can use to enhance your teaching and mentor in an impactful way for your learners.
Host Kathy Schott, PhD CEimpact
Guests Lily Gardner, PharmD Candidate 2023 Drake University
Keaton Higgins, PharmD Candidate 2023 University of Iowa
At the end of this course, preceptors will be able to:
1. Identify practices that pharmacy learners most value in their preceptors and why
2. Describe effective strategies to enhance learning in the pharmacy education experience you provide
UAN: 0107-0000-23-116-H99-P Release Date: 03/15/2023 Expiration Date: 03/15/2026 The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Want more information on this and related topics?
Check out the full course created by Dr. Cox on this topic: Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners.
As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask you experiential program director if you are a member so that you can access it all for free!
For the past two decades, large amounts of isotonic fluids have been the first step in treating septic shock despite adverse events of fluid overload, coagulopathy, and pulmonary edema. A new NIH study evaluates this strategy. Join host, Geoff Wall, with guest, Matt Trump, DO, as they evaluate initial septic shock management.
The GameChanger Liberal fluid management (30 mL/Kg) in the early phase of septic shock may not result in lower mortality than a more restrictive strategy. However, vasopressor predominant strategy may be used in its place.
Show Segments 00:00 - Introductions 01:08 - Background on Fluid Administration in Septic Shock 05:44 - Looking at the Study 15:55 - The GameChanger: Shapiro et al Results 21:21 - Connecting to Practice: What Should We Takeaway 34:31 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the background of fluid administration in septic shock 2. Describe the results of the Shapiro et al study
0.05 CEU/0.5 Hr UAN: 0107-0000-23-103-H01-P Initial release date: 03/13/2023 Expiration date: 03/13/2024 Additional CPE and CME details can be found here.
Every January, the American Diabetes Association publishes the Standards of Care in Diabetes. The guidelines are a living document and change throughout the year; however, the January update is the seminal changes for the entire document. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss what’s new and great in the guidelines.
The GameChanger In addition to medication recommendations, the guidelines now emphasize the role of Community Health Workers in the management of health-related disparities affecting patients with diabetes. Pharmacotherapy continues to be driven by comorbid conditions and the impact of clinical outcomes, like a cardiovascular or renal disease.
Show Segments 00:00 - Introductions 01:59 - Prevention and Delay of Type 2 Diabetes 08:12 - Vaccines and Diabetes 10:49 - Continuous Glucose Monitoring Goals 17:21 - Glycemic Treatment Updates 19:25 - Lipid Goals and Treatment 20:39 - The GameChanger: Treatment Recommendations with Comorbid Conditions 23:49 - Connecting to Practice: Comorbid Driven Therapy 27:31 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Managing Network Facilitator, CPESN Health Equity CEO, Seguridad
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the goal for continuous glucose monitoring in diabetes patients 2. Describe the lipid goals in patients with diabetes and treatment recommendations 3. Describe treatment recommendations for patients with diabetes and chronic kidney disease
0.05 CEU/0.5 Hr UAN: 0107-0000-23-102-H01-P Initial release date: 03/06/2023 Expiration date: 03/06/2024 Additional CPE and CME details can be found here.
Furosemide is the most prescribed loop diuretic for heart failure; however, furosemide’s pharmacokinetic parameters are less than ideal compared to other loop diuretics. Join host, Geoff Wall, as he evaluates the first randomized controlled trial comparing loop diuretics in heart failure.
The GameChanger Torsemide has potential pharmacokinetic advantages compared to furosemide in the treatment of heart failure. However, a recent study did not find meaningful differences in clinical outcomes when comparing loop diuretics for the treatment of heart failure.
Show Segments 00:00 - Introduction 01:00 - Current Loop Diuretic Use 02:21 - Furosemide vs Torsemide Pharmacokinetics 04:58 - Looking at the TRANSFORM-HF Study 14:54 - The GameChanger: TRANSFORM-HF Outcomes 19:16 - Connecting to Practice: Picking Between the Two 21:52 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. List the pharmacokinetic differences between furosemide and torsemide 2. Discuss the findings of the Mentz et al study evaluating loop diuretics
0.05 CEU/0.5 Hr UAN: 0107-0000-23-101-H01-P Initial release date: 02/27/2023 Expiration date: 02/27/2024 Additional CPE and CME details can be found here.
Routine pediatric vaccines are declining and 97% of pediatric influenza deaths are in unvaccinated children. Join host Geoff Wall, with guest Jake Galdo, as they discuss what the heck is happening with pediatric vaccines and how the healthcare community can step up.
The GameChanger The Advisory Committee on Immunization Practices provides recommendations for routine vaccines for all persons. Pharmacists are an integral part of ensuring adherence to vaccine schedules. Differences in state scope of practice may influence what vaccines may be administered, but not what vaccines can be recommended.
Show Segments 00:00 - Introductions 00:53 - Pediatric Vaccine Coverage 02:51 - Connecting to Practice: How Pharmacists Can Help 14:21 - The GameChanger: Pediatric COVID Vaccines 26:22 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Managing Network Facilitator, CPESN Health Equity CEO, Seguridad
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the current state of pediatric vaccinations in the US 2. Describe clinical information to be collected during pediatric vaccinations
0.05 CEU/0.5 Hr UAN: 0107-0000-23-100-H01-P Initial release date: 02/20/2023 Expiration date: 02/20/2024 Additional CPE and CME details can be found here.
As preceptors, sometimes one of the hardest things we do is give feedback. What about when we receive it? Listen to learn how to engage students in ways that result in meaningful feedback you can use to improve your teaching. You're putting in the work. Why not make it as impactful as possible for your learners?
This week I’m speaking with Nick Cox – a faculty member and preceptor in an ambulatory care setting – on the topic of feedback – how to invite it, how to prepare to receive it, and what to do with it when you like it – or not.
At the end of this course, preceptors will be able to:
1. List common barriers that prevent learners from providing meaningful feedback to preceptors.
2. Describe ways to create a learning environment where students feel they can safely offer feedback.
UAN: 0107-0000-23-092-H99-P Release Date: 02/15/2023 Expiration Date: 02/15/2026 The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Want more information on this and related topics?
Check out the full course created by Dr. Cox on this topic: Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners.
As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free!
Thrombolytic Use in Persons with Stroke and Direct Oral Anticoagulants
13 Feb 2023
00:27:38
Patient use of any anticoagulation during an acute stroke is a contraindication for the use of thrombolytics or clot busters. Recent meta-analyses and animal studies raise the question of this contraindication. Join guest, Geoff Wall, as he examines the data on Direct Oral Anticoagulants (DOACs) and thrombolytics.
The GameChanger DOACs have a significantly smaller intracranial hemorrhage (ICH) risk compared to warfarin and this benefit may translate to risk of bleed with thrombolytics. A new study found a numerically decreased risk of ICH in patients with DOACs compared to controls.
Show Segments 00:00 - Introductions 01:07 - Current Practices with Thrombolytics 05:05 - Looking at the Study 19:45 - The GameChanger: Decreased ICH Risk? 23:30 - Study Limitations 26:11 - Connecting to Practice 27:01 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the theory about why DOACs may not increase risk of intracranial bleed in stroke patients receiving thrombolytics 2. Describe the limitations of the Meinel et al study
0.05 CEU/0.5 Hr UAN: 0107-0000-23-064-H01-P Initial release date: 02/13/2023 Expiration date: 02/13/2024 Additional CPE and CME details can be found here.
Osteoporosis may be a forgotten disease – common but rarely treated. The 2023 guidelines are not here. Join host, Geoff Wall, as he reviews the new treatment recommendations and how we can optimize pharmacotherapy for all persons with osteoporosis.
The GameChanger Osteoporosis is common and routine screenings should be implemented. Bisphosphonates are still the drug of choice, but treatment for persons over 65 should be made on a case-by-case basis.
Show Segments 00:00 - Introduction 00:25 - Background on Osteoporosis 04:17 - How Guidelines Are Formed 08:45 - Bisphosphonate Recommendation 14:14 - Denosumab Recommendation 16:40 - Anabolic Drugs 20:40 - SERMs 22:24 - The GameChanger: Recommendations Summary 27:20 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the epidemiology and diagnosis of osteoporosis 2. Apply the treatment guidelines for osteoporosis to a specific patient
0.05 CEU/0.5 Hr UAN: 0107-0000-23-063-H01-P Initial release date: 01/06/2023 Expiration date: 01/06/2024 Additional CPE and CME details can be found here.
Hydrochlorothiazide is the go-to thiazide for hypertension control despite better data for chlorthalidone. Join host Geoff Wall as he evaluates the new randomized controlled study to determine what is the best thiazide.
The GameChanger Several pharmacologic differences exist between hydrochlorothiazide and chlorthalidone. The new DCP Study did not find any differences in cardiovascular outcomes.
Show Segments 00:00 - Introductions 02:20 - History of HCTZ vs Chlorthalidone 05:26 - The Diuretic Comparison Project: HCTZ vs Chlorthalidone 12:27 - The GameChanger: DCP Results 19:48 - Connecting to Practice: Choosing Between the Two 21:47 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the pharmacologic differences of hydrochlorothiazide and chlorthalidone 2. Apply the results of the DCP Study to clinical practice
0.05 CEU/0.5 Hr UAN: 0107-0000-23-025-H01-P Initial release date: 01/30/2023 Expiration date: 01/30/2024 Additional CPE and CME details can be found here.
In this week's episode, we dive into the fascinating world of gut health, including three actionable tips you can provide to patients. Explore the critical role of gut microbiome in health conditions ranging from autoimmune disorders to mental health to skin conditions.
The GameChanger Health outcomes can be significantly impacted by addressing gut health issues through dietary modifications, understanding drug-nutrient depletions, and promoting the use of probiotics and prebiotics.
Guest Anna Garrett, PharmD, BCPS President, AnnaGarrett.com
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the relationship between gut health and systemic conditions. 2. Identify strategies for assessing and addressing gut health issues, including dietary modifications, the use of probiotics and prebiotics, and the identification of drug-nutrient depletions.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-221-H01-P Initial release date: 07/15/2024 Expiration date: 07/15/2025 Additional CPE details can be found here.
Results from early COVID-19 studies are still emerging. Some micronutrients, such as zinc, have been shown to decrease the severity of viral infections yet human data is sparse. Join host, Geoff Wall, as he evaluates a new study looking at the proposed benefit of zinc in COVID-19 infections.
The GameChanger Zinc has several antiviral properties. A recent trial showed a decreased risk of ICU admission – however, has numerous exclusion criteria impacting the external validity.
Show Segments 00:00 - Introductions 01:45 - Zinc Role In COVID-19 04:20 - Looking at the Study 10:33 - The GameChanger: Study Results 19:03 - Connecting to Practice: Applicability of Exclusions 21:48 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the putative role of zinc in treating COVID-19 2. Describe the application of the results of the Zinc COVID-19 study
0.05 CEU/0.5 Hr UAN: 0107-0000-23-025-H01-P Initial release date: 01/23/2023 Expiration date: 01/23/2024 Additional CPE and CME details can be found here.
Asking the Right Questions of Your Students and Residents
18 Jan 2023
00:42:08
Sometimes teaching isn't "telling" but "asking" - asking questions that encourage students and residents to problem-solve in a stepwise manner. Listen in as we discuss a teaching strategy that builds confidence and encourages curiosity in your learners.
We’ve all heard students and residents complain about ‘pimping’ from preceptors during rotations or during their residency experience. Pimping has given a bad name to what can truly be a very effective teaching strategy when done right – Socratic Questioning.
In this month's episode, I’m speaking with Lindsay Davis of Midwestern University – Glendale, and Kevin Carrasco, a preceptor who has jumped on the Socratic Questioning bandwagon after experiencing what a difference it has made in his effectiveness as a preceptor. During our conversation – they debunked many of the assumptions often made about Socratic questioning as a teaching method and also gave some great advice on how to approach this method in a trusting and safe way for learners.
Guests Lindsay Davis Lindsay E. Davis, PharmD, BCPS, BCCP, FCCP Director, Cardiology & Metabolism Team Pfizer, Internal Medicine Field Medical Group Adjunt Professor, Pharmacy Practice Midwestern University - Glendale
Kevin Carrasco, Pharm.D., MPH Emergency Medicine Pharmacist Banner Univeristy Phoenix Pharmacy
Dr. Davis reports that she is employed by Pfizer. All relevant financial relationships have been mitigated.
At the end of this course, preceptors will be able to:
1. Define the concept of 'microaggression'
2. Identify strategies to support students who may experience microaggressions during experiential learning
UAN: 0107-0000-23-058-H99-P Release Date: 01/18/2022 Expiration Date: 01/18/2025 The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Want more information on this and related topics?
Check out this free resource to guide the implementation of Socratic Questioning in your teaching.
As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free!0
Celiac disease is of the most common auto-immune diseases in the world. The only current treatment is maintaining a strict gluten-free diet. Join host, Geoff Wall, as he discusses the results of a phase 2 study investigating a novel pharmacologic treatment of Celiac disease.
The GameChanger Celiac disease is common and has a myriad of symptoms. A new drug may offer a way for patients with Celiac disease to eat gluten without issue.
Show Segments 00:00 - Introductions 00:50 - The Effects of Celiac Disease 03:45 - Why Celiac Causes Problems 09:08 - Latiglutenase Study Background 14:48 - The GameChanger: Latiglutenase Study Results 19:11 - Connecting to Practice 21:31 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
References and Resources
Murray JA, Syage JA, Wu TT, et al. Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge. Gastroenterology. 2022 Dec;163(6):1510-1521.e6. doi: 10.1053/j.gastro.2022.07.071. Epub 2022 Aug 2. PMID: 35931103; PMCID: PMC9707643.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the extraintestinal manifestations of Celiac disease 2. Discuss the Murray et al study and its implications in patients with Celiac disease
0.05 CEU/0.5 Hr UAN: 0107-0000-23-024-H01-P Initial release date: 01/16/2023 Expiration date: 01/16/2024 Additional CPE and CME details can be found here.
The American Diabetes Association Standards of Care in Diabetes are a “living” guideline – the recommendations are updated throughout the year and major revisions occur in January. In this episode, guest host, Jake Galdo, is joined by Susan Cornell as they evaluate new pharmacotherapy recommendations in the ADA Standards of Care.
The GameChanger Treatment recommendations for diabetes are no longer metformin plus. Now initial, and augmented therapy, is driven by comorbid conditions.
Show Segments 00:00 - Introductions 02:09 - Reason for ADA Standards of Care Update 05:09 - The GameChanger: Comorbid Condition-Driven Therapy 08:32 - Connecting to Practice: Clinical Decision Points 11:13 - Diabetes Therapies Use for Weight Loss and Drawbacks 13:29 - Lifestyle Modification Suggestions 19:48 - Insulin Use According to New Guidelines 25:03 - Pharmacy Intervention Opportunity: Glucagon 26:37 - Closing Remarks
Host John A Galdo, PharmD, MBA, BCPS, BCGP (Jake) Director, Education Projects, CEimpact CEO, Seguridad
Guest Susan Cornell, BS, PharmD, CDCES, FAPhA, FADCES Associate Director, Experiential Education Professor, Pharmacy Practice Midwestern University College of Pharmacy
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify the first line therapy for treatment of diabetes 2. Discuss key clinical decision points for the treatment of diabetes
0.05 CEU/0.5 Hr UAN: 0107-0000-23-023-H01-P Initial release date: 01/09/2023 Expiration date: 01/09/2024 Additional CPE and CME details can be found here.
Stimulant medications, like methylphenidate and amphetamines, have adverse cardiovascular effects, like elevated blood pressure, increasing the risk of cardiovascular events. Join host Geoff Wall as he reviews a new meta-analysis trying to quantify the risk of ADHD medications on cardiovascular outcomes.
The GameChanger A large meta-analysis did not find an association between medications for ADHD and cardiovascular disease. Several limitations may interfere with the applicability of these results.
Show Segments 00:00 - Introductions 01:38 - Background on ADHD and Stimulant Medications 02:58 - Rationale for Analysis 06:42 - Looking at the Meta-Analysis 11:44 - The GameChanger: Meta-Analysis Findings 17:43 - Connecting to Practice: Addressing Patient Concerns 20:00 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the purported mechanism of the potential risk of cardiovascular disease in patients taking stimulant medications 2. Discuss the findings of a recent meta-analysis by Zhang et al on cardiovascular disease and stimulant medications
0.05 CEU/0.5 Hr UAN: 0107-0000-23-016-H01-P Initial release date: 01/03/2023 Expiration date: 01/03/2024 Additional CPE and CME details can be found here.
COPD is a common and complex disease for both inpatient and outpatient providers. GOLD guidelines provide diagnosis and treatment recommendations for COPD and were recently updated. Join host Geoff Wall as he breaks down the salient recommendations in the 2023 GOLD guidelines.
The GameChanger A new severity scoring system for COPD exists – category E. Additionally, inhaled corticosteroids may play a larger role in the pharmacotherapy of COPD.
Show Segments 00:00 - Introductions 01:40 - Background on COPD 04:09 - The GameChanger: Severity Scoring Changes 08:23 - Connecting to Practice: Impact of Inhaler Technique 16:08 - Use of Inhaled Corticosteroids 23:23 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the new severity scoring system for COPD in the 2023 GOLD guidelines 2. Discuss appropriate use of inhaled corticosteroids in COPD patients
0.05 CEU/0.5 Hr UAN: 0107-0000-22-422-H04-P Initial release date: 12/20/2022 Expiration date: 12/20/2023 Additional CPE and CME details can be found here.
Help the Hurt - Support Students and Residents Who Experience Microgressions
21 Dec 2022
00:19:20
We’ve heard a lot about microaggressions in the past couple of years. A microaggression can include verbal, behavioral, or environmental aggressions that negatively communicate about race, culture, or gender. They can be intentional or unintentional but can negatively impact healthcare interactions – whether those involve students, residents, patients, or all of the above.
In this episode, speaking with Anisa Hansen, a clinical pharmacist who leads diversity, equity, and inclusion initiatives for the College of Pharmacy and Health Sciences at Drake. Her passion is educating learners on topics in the areas of mental health, LGBTQ health and wellness, and equity and inclusion. Anisa has first-hand experience supporting students who have experienced microaggressions as part of their pharmacy practice experiences. Listen to learn more about how she has navigated those situations to support students.
Guests Anisa Hansen, PharmD Professor of Pharmacy Practice Drake University College of Pharmacy and Health Sciences
Anisa Hansen, PharmD, is a Professor of Pharmacy Practice at Drake University in Des Moines, Iowa. She has a passion for educating students on mental health, wellness, LGBTQ health, and equity and inclusion. Anisa teaches a 3-credit J-Term course focused on LGBTQ Health Issues and a first-year course exploring the portrayal of mental illness and disabilities in the media. Anisa is the mental health clinical pharmacist for Iowa Lutheran Hospital. She provides clinical service, educates sixth-year pharmacy students, and provides medication education groups in outpatient and inpatient settings.
Gabapentin is often used in a multi-model pain management strategy in both peri- and post-operative setting. Little data exists looking at the adverse effects of this practice. Join host Geoff Wall, as he reviews data from a new study looking at this question.
The GameChanger Gabapentin’s data is sparse for use in postoperative pain; however, new data suggest use after orthopedic surgery is associated with poor outcomes.
Show Segments 00:00 - Introductions 00:58 - The Current Use of Gabapentin 03:19 - Perioperative Gabapentin Study 09:34 - GameChanger: Study Findings 15:30 - Connecting to Practice: Gabapentin on Order Sets 16:52 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Apply the results of the gabapentin study to the perioperative patient population 2. Discuss the evidence of the effectiveness of gabapentin in multi-modal pain management
0.05 CEU/0.5 Hr UAN: 0107-0000-22-441-H04-P Initial release date: 12/16/2022 Expiration date: 12/16/2023 Additional CPE and CME details can be found here.
The standard of care for pancreatitis has been aggressive (liters) of intravenous fluids. New data suggests that this level of fluid resuscitation may not be needed – and possibly harmful. Join host Geoff Wall as he evaluates the role of fluids in pancreatitis treatment.
The GameChanger In patients with mild disease, moderate fluid resuscitation is safer than aggressive fluid use.
Show Segments 00:00 - Introduction 01:17 - Current Standard of Care 04:37 - The WATERFALL Study 10:20 - GameChanger: Study Findings 16:00 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the current standard of care for treating pancreatitis 2. Describe the findings of the WATERFALL study and how it applies to patients
0.05 CEU/0.5 Hr UAN: 0107-0000-22-440-H04-P Initial release date: 12/09/2022 Expiration date: 12/09/2023 Additional CPE and CME details can be found here.
A recent study showed that ethanol abuse is a leading cause of death in young adults in the US and that rates of alcoholism have increased. Join host Geoff Wall as he reviews the treatment of ethanol withdrawal.
The GameChanger Ethanol abuse is a leading cause of death in young adults. Fortunately, multiple therapies exist to treat hospitalized patients with acute ethanol withdrawal.
Show Segments 00:00 - Introductions 01:44 - Alcohol Abuse and Mortality in the United States 03:38 - GameChanger: Study Results 06:15 - Connecting to Practice: Alcohol Withdrawl Syndrome Treatment 24:11 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the epidemiology of alcohol abuse and mortality in the United States 2. Describe treatment of the hospitalized patient with acute ethanol abuse
0.05 CEU/0.5 Hr UAN: 0107-0000-22-435-H04-P Initial release date: 12/06/2022 Expiration date: 12/06/2023 Additional CPE and CME details can be found here.
On this week's GameChangers episode, we discuss prevention of recurrent UTIs, including whether use of d-mannose or antibiotics are effective.
The GameChanger Recurrent urinary tract infections plague some women throughout their lives. There are ways to prevent recurrent UTIs, however a recent study determined that d-mannose is not effective. We discuss what is effective.
Guest Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe non-pharmacologic strategies proven to decrease recurrent UTIs. 2. Discuss selection of an antibiotic and a selected patient for continuous prophylaxis.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-220-H01-P Initial release date: 07/08/2024 Expiration date: 07/08/2025 Additional CPE details can be found here.
Obesity is still at epidemic levels in the United States. More and more medications are coming to market to help with weight loss. The American Gastroenterological Association (AGA) just released guidelines for evidence-based care for persons with obesity.
The GameChanger Guidelines are now available for the treatment of obesity. The evidence-based recommendations will help providers determine appropriate therapy for persons with obesity.
Show Segments 00:00 - Introduction 01:16 - The Obesity Epidemic in the United States 05:57 - Looking at the AGA Obesity Guidelines 16:30 - AGA Obesity Guidelines: Combination Products 26:25 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the framework of the 2022 AGA obesity guidelines 2. Apply the guideline recommendations to persons with obesity
0.05 CEU/0.5 Hr UAN: 0107-0000-22-428-H01-P Initial release date: 11/28/2022 Expiration date: 11/28/2023 Additional CPE and CME details can be found here.
Health Equity is achieved when every person has the opportunity to attain their full health potential and no one is disadvantaged. Oftentimes, this is evaluated and addressed through resolving social determinants of health. A recent study evaluated the impact of food insecurity on cardiovascular outcomes. Join host, Geoff Wall, as he discusses how healthcare teams can address food insecurity with guest Jake Galdo.
The GameChanger Increased screening, identification, and referrals are needed to address the negative consequences of food insecurity on cardiovascular outcomes.
Show Segments 00:00 - Introductions 00:55 - Background on the Issue 05:45 - Looking at the Study 13:00 - The GameChanger: Results of the Study 15:40 - Connecting to Practice 26:54 - Closing Remarks
Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Guest John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake) Director, CEimpact Pharmacist, Ross Bridge Pharmacy CEO, Seguridad, Inc
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the prevalence of food insecurity in patients with cardiovascular disease 2. Discuss the role of the healthcare team in addressing food insecurity
0.05 CEU/0.5 Hr UAN: 0107-0000-22-425-H04-P Initial release date: 11/16/2022 Expiration date: 11/16/2023 Additional CPE and CME details can be found here.
Incorporating Risk Management Principles into Your Teaching
16 Nov 2022
00:46:33
Whose job is it to teach risk management principles to pharmacy learners? Sure – they have to take a law course as part of their curricular requirements, but how much does that mean to them until they are in real life situations as part of their IPPEs, APPEs, or residency? As preceptors, it’s important that we not only recognize and manage the legal risks of welcoming pharmacy learners within our pharmacy practice but also that we are prepared to teach practical concepts such as risk management in addition to developing their clinical skills. Listen to this episode where we talk with David Brushwood, a well-known expert, and educator in the practical and professional aspects of risk management and pharmacy law.
Host Kathy Schott, PhD CEimpact
Guests David Brushwood, RPh, JD Senior Lecturer, University of Wyoming School of Pharmacy Professor Emeritus, University of Florida Content Development, CEimpact
David Brushwood graduated with degrees in pharmacy and law from the University of Kansas. He practiced both professions prior to entering academia. David retired from the University of Florida, College of Pharmacy, in 2014 where he is currently Professor Emeritus of Pharmaceutical Outcomes and Policy. In 2015, David joined the faculty at the University of Wyoming, School of Pharmacy, and he serves there as a Senior Lecturer teaching online courses in the Master of Science in Health Services Administration program. David is a pharmacy law content developer with CEimpact, where he produces educational programs for pharmacists, pharmacy technicians, and pharmacy students. David’s primary research interests are pain management policy, patient safety regulation, and pharmacist professional responsibility.
At the end of this course, preceptors will be able to:
1. Describe situations where exposure to malpractice liability may occur for preceptors during experiential learning
2. Discuss techniques for teaching risk management to pharmacy learners in the experiential learning setting
UAN: 0107-0000-22-422-H99-P Release Date: 11/16/2022 Expiration Date: 11/16/2025 The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.